Pilulka Lekarny as
Pilulka Lékárny a.s. operates a network of pharmacy stores under the Pilulka brand in the Czech Republic, Slovakia, Romania, Hungary, and Austria. The company distributes medicinal products; online sale of pharmacy and related goods for health; and healthy lifestyle and services under the Pilulka brand. It also operates Internet portals, such as Pilulka.cz, Pilulka.sk, Pilulka.ro, Pilulka.hu, and… Read more
Pilulka Lekarny as (PINK) - Net Assets
Latest net assets as of : Kč- CZK
Based on the latest financial reports, Pilulka Lekarny as (PINK) has net assets worth Kč- CZK as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Kč-) and total liabilities (Kč-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Kč- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | -144.37% |
| 10-Year Change | N/A |
| Growth Volatility | 193.37 |
Pilulka Lekarny as - Net Assets Trend (2018–2024)
This chart illustrates how Pilulka Lekarny as's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Pilulka Lekarny as (2018–2024)
The table below shows the annual net assets of Pilulka Lekarny as from 2018 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Kč-96.75 Million | -415.07% |
| 2023-12-31 | Kč30.71 Million | -77.90% |
| 2022-12-31 | Kč138.93 Million | -31.93% |
| 2021-12-31 | Kč204.10 Million | -6.40% |
| 2020-12-31 | Kč218.06 Million | +170.23% |
| 2019-12-31 | Kč80.69 Million | +152.37% |
| 2018-12-31 | Kč31.97 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Pilulka Lekarny as's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 50298000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | Kč458.62 Million | % |
| Total Equity | Kč-93.97 Million | 100.00% |
Pilulka Lekarny as Competitors by Market Cap
The table below lists competitors of Pilulka Lekarny as ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Solidwizard Technology Co., Ltd.
TWO:8416
|
$50.05K |
|
ARTIS REAL EST.INV.TR.UTS
F:5G6
|
$50.05K |
|
EGIE3F
SA:EGIE3F
|
$50.07K |
|
Canoe Mining Ventures Corp
PINK:CNMVF
|
$50.08K |
|
289860
KO:289860
|
$50.03K |
|
Firstec Co. Ltd.
KQ:010820
|
$50.03K |
|
Optimus Healthcare Services Inc
PINK:OHCS
|
$50.02K |
|
MINT Income Fund
TO:MID-UN
|
$50.00K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Pilulka Lekarny as's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 32,846,000 to -93,975,000, a change of -126,821,000 (-386.1%).
- Net loss of 125,743,000 reduced equity.
- Other factors decreased equity by 1,078,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Kč-125.74 Million | -133.8% |
| Other Changes | Kč-1.08 Million | -1.15% |
| Total Change | Kč- | -386.11% |
Book Value vs Market Value Analysis
This analysis compares Pilulka Lekarny as's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | Kč13.08 | Kč126.00 | x |
| 2019-12-31 | Kč34.62 | Kč126.00 | x |
| 2020-12-31 | Kč90.17 | Kč126.00 | x |
| 2021-12-31 | Kč80.90 | Kč126.00 | x |
| 2022-12-31 | Kč55.01 | Kč126.00 | x |
| 2023-12-31 | Kč12.13 | Kč126.00 | x |
| 2024-12-31 | Kč-34.72 | Kč126.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Pilulka Lekarny as utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -9.64%
- • Asset Turnover: 5.50x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-104.57%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | -78.18% | -2.53% | 3.22x | 9.57x | Kč-28.83 Million |
| 2019 | -50.49% | -3.32% | 3.35x | 4.55x | Kč-52.35 Million |
| 2020 | -11.26% | -1.44% | 3.57x | 2.19x | Kč-48.42 Million |
| 2021 | -12.56% | -1.08% | 4.04x | 2.88x | Kč-46.11 Million |
| 2022 | -46.92% | -2.69% | 4.04x | 4.32x | Kč-79.77 Million |
| 2023 | -532.62% | -8.21% | 4.85x | 13.39x | Kč-178.23 Million |
| 2024 | 0.00% | -9.64% | 5.50x | 0.00x | Kč-116.35 Million |
Industry Comparison
This section compares Pilulka Lekarny as's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
No peer company data available for comparison.